Effectiveness of direct-acting antiviral therapy for hepatitis C in difficult-to-treat patients in a safety-net health system: a retrospective cohort study

BACKGROUND: Direct-acting antivirals (DAAs) have revolutionized chronic hepatitis C (HCV) treatment, but real-world effectiveness among vulnerable populations, including uninsured patients, is lacking. This study was conducted to characterize the effectiveness of DAAs in a socioeconomically disadvan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yek, Christina, de la Flor, Carolina, Marshall, John, Zoellner, Cindy, Thompson, Grace, Quirk, Lisa, Mayorga, Christian, Turner, Barbara J., Singal, Amit G., Jain, Mamta K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694912/
https://www.ncbi.nlm.nih.gov/pubmed/29151365
http://dx.doi.org/10.1186/s12916-017-0969-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5694912/
https://www.ncbi.nlm.nih.gov/pubmed/29151365
http://dx.doi.org/10.1186/s12916-017-0969-3

Ejemplares similares